Communiqués BenevolentAI

Actions

BAI

LU2355630455

Marché Fermé - Euronext Amsterdam Autres places de cotation 17:29:58 06/06/2024			Varia. 5j.	Varia. 1 janv.
0,5 ^EUR	-5,30 %		-10,71 %	-53,70 %

15/05	BenevolentAI annonce un nouveau succès dans sa collaboration avec AstraZeneca avec la sélection d'une nouvelle cible pour l'insuffisance cardiaque	CI
02/05	Benevolentai S.A. annonce des changements de direction	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BenevolentAI to participate in Goldman Sachs 45th Annual Global Healthcare Conference	04/06	BU
BenevolentAI Announces Further Success With AstraZeneca Collaboration as Novel Heart Failure Target Selected	15/05	BU
BenevolentAI - Result of Annual General Meeting	03/05	AQ
BenevolentAI : Benevolent AI, - Result of Annual General Meeting	02/05	PU
BenevolentAI: Result of Annual General Meeting	02/05	BU
BenevolentAI : Major shareholding notifications Major shareholding notification	01/05	PU
BenevolentAI : Benevolent AI, - BenevolentAI provides an update on its business priorities	23/04	PU
BenevolentAI Provides an Update on Its Business Priorities	23/04	BU
BenevolentAI - Publication of the Revised Agenda for the 2024 AGM	18/04	AQ
BenevolentAI : Benevolent AI, - Publication of the Revised Agenda for the 2024 AGM	17/04	PU
BenevolentAI : Inside Information / Ad Hoc Information Publication of the Revised Agenda for the 2024 AGM	17/04	PU
BenevolentAI: Publication of the Revised Agenda for the 2024 AGM	17/04	BU
Proposed changes to BenevolentAI's Board composition	16/04	AQ
Proposed Changes to BenevolentAI’s Board Composition	15/04	BU
BenevolentAI : Inside Information / Ad Hoc Information BenevolentAI announces positive topline safety and pharmacokinetic data from the Phase Ia clinical study of BEN-8744 in healthy volunteers	25/03	PU
BenevolentAI Announces Positive Topline Safety and Pharmacokinetic Data from the Phase Ia Clinical Study of BEN-8744 in Healthy Volunteers	25/03	BU
Benevolent AI CEO discusses 2023 highlights and 2024 outlook as it pioneers AI in drug discovery	21/03	AQ
BenevolentAI : Benevolent AI, - Publication of 2023 Annual Report and 2024 AGM Notice	20/03	PU
BenevolentAI : Inside Information / Ad Hoc Information Publication of 2023 Annual Report and 2024 AGM Notice	20/03	PU
BenevolentAI Appoints New Chief Technology Officer	20/03	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués BenevolentAI

Actions

BAI

LU2355630455

Communiqués

Filtres